TET3 mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1A-AS1

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 11, 2014, Pages 7744-7751

  Zhang, Qing Qing ^a   Xu, Ming Yi ^a   Qu, Yin ^a   Hu, Jun Jie ^a   Li, Zheng Hong ^a   Zhang, Qi Di ^a   Lu, Lun Gen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

HIF1A AS1; HSCs; Liver fibrosis; Long non coding RNA; Tet3

Indexed keywords

DIOXYGENASE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LONG UNTRANSLATED RNA; TET3 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HUMAN; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; STELLATE CELL;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; DIOXYGENASES; HEPATIC STELLATE CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER CIRRHOSIS; RNA, LONG NONCODING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84920191550     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bataller R and Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
2. Wang X, Hu F, Hu X, Chen W, Huang Y and Yu X. Proteomic identification of potential Clonorchis sinensis excretory/secretory products capable of binding and activating human hepatic stellate cells. Parasitol Res 2014; 113: 3063-3071.
3. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-172.
4. Lee UE and Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011; 25: 195-206.
5. Gressner OA and Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008; 28: 1065-1079.
6. Olaso E and Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998; 29: 836-847.
7. Moles A, Sanchez AM, Banks PS, Murphy LB, Luli S, Borthwick L, Fisher A, O'Reilly S, van Laar JM, White SA, Perkins ND, Burt AD, Mann DA, Oakley F. Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response. Hepatology 2013; 57: 817-828.
8. Wu SC and Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 2010; 11: 607-620.
9. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324: 930-935.
10. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC and Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466: 1129-1133.
11. Pastor WA, Aravind L and Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol 2013; 14: 341-356.
12. Müller T, Gessi M, Waha A, Isselstein LJ, Luxen D, Freihoff D, Freihoff J, Becker A, Simon M, Hammes J, Denkhaus D, Zur Mühlen A, Pietsch T, Waha A. Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas. Am J Pathol 2012; 181: 675-683.
13. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, Xu ZD, Zhu HG, Ling ZQ, Ye D, Guan KL, Xiong Y. Tumor development is associated with decrease of TET gene expression and 5-methyl-cytosine hydroxylation. Oncogene 2012; 32: 663-669.
14. Ji J, Zhang J, Huang G, Qian J, Wang X and Mei S. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 2009; 583: 759-766.
15. Guo CJ, Pan Q, Li DG, Sun H and Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol 2009; 50: 766-778.
16. Zhang Y, Ghazwani M, Li J, Sun M, Stolz DB, He F, Fan J, Xie W, Li S. MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase. Biochem Biophysical Res Commun 2014; 446: 940-944.
17. Gao L, Mai A, Li X, Lai Y, Zheng J, Yang Q, Wu J, Nan A, Ye S, Jiang Y. LncRNA-DQ786227-mediated cell malignant transformation induced by benzo (a) pyrene. Toxicol Lett 2013; 223: 205-210.
18. Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J, Jin Y, Zheng X, Wu Y, Fu H. The long noncoding rna expression profile of hepatocellular carcinoma identified by microarray analysis. PLoS One 2014; 9: e101707.
19. Zhao Y, Wang Y, Wang Q, Liu Z, Liu Q and Deng X. Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway. Mol Cell Biochem 2012; 359: 217-223.
20. Cheng JH, She H, Han YP, Wang J, Xiong S, Asahina K, Tsukamoto H. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008; 294: G39-G49.
21. Bian EB, Zong G, Xie YS, Meng XM, Huang C, Li J, Zhao B. TET family proteins: new players in gliomas. J Neurooncol 2014; 116: 429-435.
22. Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, Tsai CH, Chu CS, Jeng YM, Chen YT, Lin FM, Huang HD, Lu YY, Teng YC, Lin ST, Lin RK, Tang FM, Lee SB, Hsu HM, Yu JC, Hsiao PW, Juan LJ. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep 2012; 2: 568-579.
23. Yang Y, Li H, Hou S, Hu B, Liu J and Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One 2013; 8: e65309.
24. Song X, Cao G, Jing L, Lin S, Wang X, Zhang J, Wang M, Liu W, Lv C. Analysing the relationship between lncRNA and protein - coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis. J Cell Mol Med 2014; 18: 991-1003.